Pharma Journalist -

Proteostasis Therapeutics, a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other…
Read More...

Nicox SA and Ocumension Therapeutics announced that they have entered into an exclusive license agreement for the development and commercialization of Nicox’s product candidate, NCX…
Read More...

SMi Group’s next annual Adaptive Designs in Clinical Trials conference is thrilled to welcome Sandeep Menon, Vice President and Head of Early Clinical Development at Pfizer Inc. onto…
Read More...

SMi Reports: Chief Scientific Officer of MiNA Therapeutics set to speak at RNA Therapeutics 2019, following MiNA Therapeutics’ successful liver cancer therapy news. The field of RNA…
Read More...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced that it exercised, and closed on its exclusive option to acquire Potenza…
Read More...

BioArctic AB (publ) announced that BioArctic and its partner AbbVie have received U.S. Federal Trade Commission (FTC) clearance to license BioArctic's alpha-synuclein antibody portfolio…
Read More...

Innovent Biologics, Inc. (Innovent)  and Incyte announced that the companies, through their respective subsidiaries, have entered into a strategic collaboration agreement for three…
Read More...

AMAG Pharmaceuticals announced it has entered into a definitive agreement to acquire Perosphere Pharmaceuticals Inc., a private biopharmaceutical company. Through this acquisition, AMAG…
Read More...

The Global Antibiotic Research and Development Partnership (GARDP), Eisai Co., Ltd. and Takeda Pharmaceutical Company Limited have signed an agreement for GARDP to access and screen…
Read More...

Novartis announced that the European Commission (EC) has approved Xolair (omalizumab) prefilled syringe (PFS) for self-administration, allowing patients with severe allergic asthma…
Read More...